VERA THERAPEUTICS INC's ticker is VERA and the CUSIP is 92337R101. A total of 80 filers reported holding VERA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.85 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,134,661 | -14.6% | 301,580 | 0.0% | 0.27% | +2.3% |
| Q2 2023 | $4,840,359 | +106.8% | 301,580 | 0.0% | 0.26% | +100.0% |
| Q1 2023 | $2,340,261 | -59.9% | 301,580 | 0.0% | 0.13% | -61.7% |
| Q4 2022 | $5,835,573 | -9.2% | 301,580 | 0.0% | 0.34% | +3.4% |
| Q3 2022 | $6,427,000 | +56.6% | 301,580 | 0.0% | 0.33% | +47.1% |
| Q2 2022 | $4,105,000 | -42.1% | 301,580 | 0.0% | 0.22% | -3.0% |
| Q1 2022 | $7,084,000 | -62.9% | 301,580 | -57.7% | 0.23% | -50.0% |
| Q4 2021 | $19,069,000 | +16.3% | 713,658 | -24.5% | 0.46% | +18.3% |
| Q3 2021 | $16,392,000 | +30.8% | 944,791 | 0.0% | 0.39% | +52.5% |
| Q2 2021 | $12,528,000 | – | 944,791 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 5,450,000 | $87,472,500 | 9.83% |
| Kynam Capital Management, LP | 3,000,000 | $48,150,000 | 6.62% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 975,227 | $15,642,641 | 4.76% |
| Sofinnova Investments, Inc. | 3,467,156 | $55,647,854 | 3.64% |
| Eversept Partners, LP | 1,740,951 | $27,942,264 | 2.34% |
| Altium Capital Management LP | 120,000 | $1,926,000 | 1.46% |
| Carlyle Group Inc. | 2,416,837 | $38,766,065 | 1.38% |
| SECTORAL ASSET MANAGEMENT INC | 351,646 | $5,643,918 | 0.94% |
| Tri Locum Partners LP | 108,928 | $1,748,294 | 0.65% |
| Orbimed Advisors | 1,756,800 | $28,196,640 | 0.51% |